Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Nova Eye Medical reports surge in USA sales despite Medicare reimbursement uncertainty
    • News

    Nova Eye Medical reports surge in USA sales despite Medicare reimbursement uncertainty

    Aussie MedTech company Nova Eye Medical (ASX: EYE) has kicked off the new year with good news for investors, recording an impressive $7.6 million in sales in the US for its glaucoma surgical devices during the six months concluding on December 31, 2023 (unaudited).  This represents a remarkable 65% growth compared to the previous corresponding

    Read More
    Public
  • US shares show unbelievable strength as bond yields and inflation expectations fall
    • Market Update

    US shares show unbelievable strength as bond yields and inflation expectations fall

    The XJO is expected to open higher this morning following renewed buying in the U.S overnight, which saw them return to being within arms reach of their all-time highs. Their futures are flat. Our market yesterday broke lower, perhaps anticipating a continued fall in the U.S. We are on the tail end of the holiday

    Read More
    Public
  • Syntara prepares for new clinical trials led by Professor Fiona Wood to restore elasticity into burn scars
    • News

    Syntara prepares for new clinical trials led by Professor Fiona Wood to restore elasticity into burn scars

    Beyond the searing pain of burns, permanent scarring of the skin has a devastating lifelong impact on quality of life. Imagine reaching up for the top shelf and having a sharp pain surge down your arm and back. Unfortunately this is the reality for millions of burn victims where skin does not heal with the

    Read More
    Public
  • Wide Open Agriculture charts new plan for 2024 following lengthy ASX suspension
    • News

    Wide Open Agriculture charts new plan for 2024 following lengthy ASX suspension

    “I have more gray hair in my beard – and less overall hair of any color –  after a year like we’ve just had,” Wide Open Agriculture (ASX: WOA) CEO Jay Albany remarked, reflecting on the Company’s 2023—the year in which it was suspended from the ASX for six months. Besides reeling under the impact

    Read More
    Public
  • Algorae teams up with HL Pharma to supply cannaboids for research projects
    • News

    Algorae teams up with HL Pharma to supply cannaboids for research projects

    Aussie pharma development company Algorae Pharmaceuticals (ASX: 1AI) has partnered with HL Pharma, an Australian company registered with the Victorian Department of Health, for the sourcing, supply, and distribution of various cannabinoid compounds for research purposes. The collaboration is governed by a comprehensive three-year agreement, adhering to Good Distribution Practice (GDP). Under the terms, HL

    Read More
    Public
  • Strong US jobs report leads to questions around expected rate cut timetable
    • Market Update

    Strong US jobs report leads to questions around expected rate cut timetable

    The XJO is expected to open flat this morning, following another night of indecisive trading in the U.S on Friday. Their futures have edged into the red. Ultimately it seems markets are consolidating as they grind along their key supports. For the U.S, that level is roughly 4,700. For the us, that level is roughly

    Read More
    Public
  • «
  • ‹
  • 133
  • 134
  • 135
  • 136
  • 137
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.